Can You Stop Myeloma Treatment and Still Stay in Remission?

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Samer Al Hadidi, M.D., M.S.(CRDSA), FACP, is an associate professor of Medicine. He earned his medical degree from University of Jordan, and his M.S.(CRDSA) at the School of Public Health and Biostatistics at the University of Michigan-Ann Arbor. Dr. Al Hadidi trained in Internal Medicine in Hurley Medical Center/Michigan State University and Hematology & Oncology in Baylor College of Medicine. Dr. Al Hadidi is a member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the American Association for Cancer Research (AACR) and the American Society for Transplantation and Cellular Therapy  (ASTCT). Dr. Al Hadidi research interests include plasma cell dyscrasias including multiple myeloma with a focus on drug development, cellular therapy, immunotherapy, health equity and medical education.